Search research articles
Contact Us
Filters
Showing results (41-50 of 54) with videos related to
Page
of 6
Sort By:
Cephalalgia : an International Journal of Headache
|
February 9, 2022
Detoxification vs non-detoxification before starting an anti-CGRP monoclonal antibody in medication overuse headache
Umberto Pensato, Carlo Baraldi, Valentina Favoni, et al.
The Journal of Headache and Pain
|
September 12, 2018
The association between migraine and physical exercise
Faisal Mohammad Amin, Stavroula Aristeidou, Carlo Baraldi, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
July 5, 2021
Real-life assessment of erenumab in refractory chronic migraine with medication overuse headache
Umberto Pensato, Carlo Baraldi, Valentina Favoni, et al.
Journal of Neurology
|
July 19, 2023
Retreating migraine patients in the second year with monoclonal antibodies anti-CGRP pathway: the multicenter prospective cohort RE-DO study
Fabrizio Vernieri, Nicoletta Brunelli, Simona Guerzoni, et al.
Cephalalgia : an International Journal of Headache
|
April 26, 2022
Self-administered subcutaneous diclofenac sodium in acute migraine attack: A randomized, double-blind, placebo-controlled dose-finding pilot study
Pierangelo Geppetti, Francesco De Cesaris, Silvia Benemei, et al.
International Journal of Environmental Research and Public Health
|
September 9, 2022
Excellent Response to OnabotulinumtoxinA: Different Definitions, Different Predictors
Raffaele Ornello, Carlo Baraldi, Fayyaz Ahmed, et al.
Pain and Therapy
|
March 29, 2021
Early Management of OnabotulinumtoxinA Treatment in Chronic Migraine: Insights from a Real-Life European Multicenter Study
Raffaele Ornello, Fayyaz Ahmed, Andrea Negro, et al.
Pain and Therapy
|
September 26, 2021
Is There a Gender Difference in the Response to onabotulinumtoxinA in Chronic Migraine? Insights from a Real-Life European Multicenter Study on 2879 Patients
Raffaele Ornello, Fayyaz Ahmed, Andrea Negro, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
March 20, 2023
Validation of the Italian version of the Cluster Headache Impact Questionnaire (CHIQ)
Agnese Onofri, Luigi Francesco Iannone, Antonio Granato, et al.
CNS Drugs
|
November 24, 2023
Long-Term Treatment Over 52 Weeks with Monthly Fremanezumab in Drug-Resistant Migraine: A Prospective Multicenter Cohort Study
Valeria Caponnetto, Antonio Russo, Marcello Silvestro, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 54) with videos related to
Sort By:
Page
of 6
Cephalalgia : an International Journal of Headache
|
February 9, 2022
Detoxification vs non-detoxification before starting an anti-CGRP monoclonal antibody in medication overuse headache
Umberto Pensato, Carlo Baraldi, Valentina Favoni, et al.
The Journal of Headache and Pain
|
September 12, 2018
The association between migraine and physical exercise
Faisal Mohammad Amin, Stavroula Aristeidou, Carlo Baraldi, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
July 5, 2021
Real-life assessment of erenumab in refractory chronic migraine with medication overuse headache
Umberto Pensato, Carlo Baraldi, Valentina Favoni, et al.
Journal of Neurology
|
July 19, 2023
Retreating migraine patients in the second year with monoclonal antibodies anti-CGRP pathway: the multicenter prospective cohort RE-DO study
Fabrizio Vernieri, Nicoletta Brunelli, Simona Guerzoni, et al.
Cephalalgia : an International Journal of Headache
|
April 26, 2022
Self-administered subcutaneous diclofenac sodium in acute migraine attack: A randomized, double-blind, placebo-controlled dose-finding pilot study
Pierangelo Geppetti, Francesco De Cesaris, Silvia Benemei, et al.
International Journal of Environmental Research and Public Health
|
September 9, 2022
Excellent Response to OnabotulinumtoxinA: Different Definitions, Different Predictors
Raffaele Ornello, Carlo Baraldi, Fayyaz Ahmed, et al.
Pain and Therapy
|
March 29, 2021
Early Management of OnabotulinumtoxinA Treatment in Chronic Migraine: Insights from a Real-Life European Multicenter Study
Raffaele Ornello, Fayyaz Ahmed, Andrea Negro, et al.
Pain and Therapy
|
September 26, 2021
Is There a Gender Difference in the Response to onabotulinumtoxinA in Chronic Migraine? Insights from a Real-Life European Multicenter Study on 2879 Patients
Raffaele Ornello, Fayyaz Ahmed, Andrea Negro, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
March 20, 2023
Validation of the Italian version of the Cluster Headache Impact Questionnaire (CHIQ)
Agnese Onofri, Luigi Francesco Iannone, Antonio Granato, et al.
CNS Drugs
|
November 24, 2023
Long-Term Treatment Over 52 Weeks with Monthly Fremanezumab in Drug-Resistant Migraine: A Prospective Multicenter Cohort Study
Valeria Caponnetto, Antonio Russo, Marcello Silvestro, et al.
Page
of 6